NO992206L - Nye reagenser og en metode for lyse av erytrocytter - Google Patents

Nye reagenser og en metode for lyse av erytrocytter

Info

Publication number: NO992206L
Authority: NO; Norway
Prior art keywords: erythrocytes; lysis; new reagents; nitrogen containing; containing heterocycle
Prior art date: 1998-05-07

Application number

NO992206A

Other languages

English (en)

Norwegian (no)

Other versions

NO992206D0 (no

Inventor

Andre Van Agthoven

David Jarrossay

Original Assignee

Immunotech Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-07

Filing date

1999-05-06

Publication date

1999-11-08

1999-05-06 Application filed by Immunotech Sa filed Critical Immunotech Sa

1999-05-06 Publication of NO992206D0 publication Critical patent/NO992206D0/no

1999-11-08 Publication of NO992206L publication Critical patent/NO992206L/no

Links

239000003153 chemical reaction reagent Substances 0.000 title abstract 4
210000003743 erythrocyte Anatomy 0.000 title abstract 2
230000009089 cytolysis Effects 0.000 title 1
239000003146 anticoagulant agent Substances 0.000 abstract 2
229940127090 anticoagulant agent Drugs 0.000 abstract 2
230000002934 lysing effect Effects 0.000 abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
-1 aliphatic aldehyde Chemical class 0.000 abstract 1
150000001450 anions Chemical class 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
150000001768 cations Chemical class 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
210000000265 leukocyte Anatomy 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Ecology (AREA)
Food Science & Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO992206A 1998-05-07 1999-05-06 Nye reagenser og en metode for lyse av erytrocytter NO992206L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9806055A FR2778413B1 (fr)	1998-05-07	1998-05-07	Nouveaux reactifs et methode de lyse des erythrocytes

Publications (2)

Publication Number	Publication Date
NO992206D0 NO992206D0 (no)	1999-05-06
NO992206L true NO992206L (no)	1999-11-08

Family

ID=9526319

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO992206A NO992206L (no)	1998-05-07	1999-05-06	Nye reagenser og en metode for lyse av erytrocytter

Country Status (11)

Country	Link
US (1)	US6143567A (de)
EP (1)	EP0955543B1 (de)
JP (2)	JPH11352125A (de)
AT (1)	ATE237806T1 (de)
AU (1)	AU747910B2 (de)
DE (2)	DE955543T1 (de)
ES (1)	ES2141073T1 (de)
FR (1)	FR2778413B1 (de)
GR (1)	GR990300041T1 (de)
NO (1)	NO992206L (de)
NZ (1)	NZ335594A (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2813891B1 (fr) *	2000-09-14	2005-01-14	Immunotech Sa	Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
US7465584B2 (en) *	2005-01-24	2008-12-16	Sysmex Corporation	Method and reagent for classifying leukocytes in animal blood
DK3035798T3 (en) *	2013-08-20	2018-11-19	Univ Yeditepe	CELL CRYO-CONSERVATION MEDIUM ADDED TO DRILL
US10577627B2 (en)	2014-06-09	2020-03-03	Voyager Therapeutics, Inc.	Chimeric capsids
EP3215191B1 (de)	2014-11-05	2024-08-14	Voyager Therapeutics, Inc.	Aadc-polynukleotide zur behandlung von morbus parkinson
KR20230145206A (ko)	2014-11-14	2023-10-17	보이저 테라퓨틱스, 인크.	조절성 폴리뉴클레오티드
CN114717264A (zh)	2014-11-14	2022-07-08	沃雅戈治疗公司	治疗肌萎缩性侧索硬化(als)的组合物和方法
US11697825B2 (en)	2014-12-12	2023-07-11	Voyager Therapeutics, Inc.	Compositions and methods for the production of scAAV
US20180230489A1 (en)	2015-10-28	2018-08-16	Voyager Therapeutics, Inc.	Regulatable expression using adeno-associated virus (aav)
EP3371591A4 (de)	2015-11-02	2018-11-14	Chiranjit Deka	Lichtstreuerbasierte vorrichtung und verfahren zur hämatologieanalyse mit verwendung von nur drei detektoren
EP3448987A4 (de)	2016-04-29	2020-05-27	Voyager Therapeutics, Inc.	Zusammensetzungen zur behandlung einer erkrankung
EP3448874A4 (de)	2016-04-29	2020-04-22	Voyager Therapeutics, Inc.	Zusammensetzungen zur behandlung einer erkrankung
IL297576B2 (en)	2016-05-18	2024-02-01	Voyager Therapeutics Inc	Compositions and methods of treating huntington's disease
US10584337B2 (en)	2016-05-18	2020-03-10	Voyager Therapeutics, Inc.	Modulatory polynucleotides
EP3831281B1 (de)	2016-08-30	2026-02-25	The Regents of The University of California	Vorrichtungen und systeme für biomedizinische zielführung und verabreichung
WO2018048586A1 (en) *	2016-09-06	2018-03-15	Chiranjit Deka	Improved reagent and method for identification and enumeration of basophils
MX2019013172A (es)	2017-05-05	2020-09-07	Voyager Therapeutics Inc	Composiciones y metodos para tratar la enfermedad de huntington.
EP3618839A4 (de)	2017-05-05	2021-06-09	Voyager Therapeutics, Inc.	Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als)
WO2018220835A1 (ja) *	2017-06-02	2018-12-06	日立化成株式会社	血液試料中の希少細胞を分離する方法及び該細胞の遺伝子を解析する方法
JOP20190269A1 (ar)	2017-06-15	2019-11-20	Voyager Therapeutics Inc	بولي نوكليوتيدات aadc لعلاج مرض باركنسون
CA3070087A1 (en)	2017-07-17	2019-01-24	Voyager Therapeutics, Inc.	Trajectory array guide system
US11512327B2 (en)	2017-08-03	2022-11-29	Voyager Therapeutics, Inc.	Compositions and methods for delivery of AAV
BR102018015288A2 (pt)	2017-08-08	2021-11-09	Euroimmun Medizinische Labordiagnostika Ag	Método para comprovar uma ativação de basófilos
EP3441763A1 (de)	2017-08-08	2019-02-13	Euroimmun Medizinische Labordiagnostika AG	Verfahren zum nachweis einer basophilenaktivierung
MX2020003042A (es)	2017-09-29	2020-11-18	Voyager Therapeutics Inc	Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
WO2019079242A1 (en)	2017-10-16	2019-04-25	Voyager Therapeutics, Inc.	TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
TW202413649A (zh)	2017-10-16	2024-04-01	美商航海家醫療公司	肌萎縮性脊髓側索硬化症(als)之治療
EP3762500A1 (de)	2018-03-06	2021-01-13	Voyager Therapeutics, Inc.	Aus insektenzelle hergestellte teilweise selbstkomplementäre aav-genome
CN112424359A (zh)	2018-05-15	2021-02-26	沃雅戈治疗公司	用于治疗帕金森氏病的组合物和方法
US20210207167A1 (en)	2018-05-16	2021-07-08	Voyager Therapeutics, Inc.	Aav serotypes for brain specific payload delivery
WO2019222444A2 (en)	2018-05-16	2019-11-21	Voyager Therapeutics, Inc.	Directed evolution
US20210254103A1 (en)	2018-07-02	2021-08-19	Voyager Therapeutics, Inc.	Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
WO2020023612A1 (en)	2018-07-24	2020-01-30	Voyager Therapeutics, Inc.	Systems and methods for producing gene therapy formulations
US12281321B2 (en)	2018-09-28	2025-04-22	Voyager Therapeutics, Inc.	Frataxin expression constructs having engineered promoters and methods of use thereof
WO2020072849A1 (en)	2018-10-04	2020-04-09	Voyager Therapeutics, Inc.	Methods for measuring the titer and potency of viral vector particles
CA3125770A1 (en)	2019-01-18	2020-07-23	Voyager Therapeutics, Inc.	Methods and systems for producing aav particles
US20220243225A1 (en)	2019-04-29	2022-08-04	Voyager Therapeutics, Inc.	SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
EP4010465A1 (de)	2019-08-09	2022-06-15	Voyager Therapeutics, Inc.	Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
EP4022070A1 (de)	2019-08-26	2022-07-06	Voyager Therapeutics, Inc.	Kontrollierte expression viraler proteine
CN111504887B (zh) *	2020-05-09	2023-05-09	苏州四正柏生物科技有限公司	一种溶血素及其制备方法
EP4192514A1 (de)	2020-08-06	2023-06-14	Voyager Therapeutics, Inc.	Zellkulturmedium zur verwendung bei der herstellung von gentherapieprodukten in bioreaktoren
WO2022187473A2 (en)	2021-03-03	2022-09-09	Voyager Therapeutics, Inc.	Controlled expression of viral proteins
WO2022187548A1 (en)	2021-03-03	2022-09-09	Voyager Therapeutics, Inc.	Controlled expression of viral proteins
WO2024054983A1 (en)	2022-09-08	2024-03-14	Voyager Therapeutics, Inc.	Controlled expression of viral proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3884579A (en) *	1973-06-14	1975-05-20	Cambridge Chemical Products In	Method for counting blood platelets
US4284412A (en) *	1979-07-13	1981-08-18	Ortho Diagnostics, Inc.	Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4637986A (en) *	1983-08-22	1987-01-20	Ortho Diagnostic Systems, Inc.	Flow cytometry lysing reagent with leukoprotective agent for producing a 3-part WBC count
US4902613A (en) *	1984-05-14	1990-02-20	Becton, Dickinson And Company	Lysing agent for analysis of peripheral blood cells
US5188935A (en) *	1984-05-31	1993-02-23	Coulter Electronics, Inc.	Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
JP2836865B2 (ja) *	1989-10-23	1998-12-14	東亜医用電子株式会社	血液中の白血球およびヘモグロビンの測定用試薬
US5316951A (en) *	1991-06-07	1994-05-31	Carver Jr Edward L	Method for the improved determination of white blood cell subpopulations
JP3177863B2 (ja) *	1992-07-17	2001-06-18	東ソー株式会社	不安定型糖化ヘモグロビンの除去方法
EP0685994B1 (de) *	1993-02-25	2007-03-21	Abbott Laboratories	Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
FR2705359B1 (fr) *	1993-05-19	1995-08-18	Immunotech Sa	Méthode de protection des cellules leucocytaires, composition protectrice, composition de sang protégée, et méthode d'analyse sanguine.
FR2705360B1 (fr) *	1993-05-19	1995-08-18	Immunotech Sa	Méthode et composition pour la lyse des érythrocytes, composition de sang, et méthode d'analyse leucocytaire.
JPH08189924A (ja) *	1994-03-07	1996-07-23	Sekisui Chem Co Ltd	安定型糖化ヘモグロビンの測定方法
JP3324050B2 (ja) *	1994-10-31	2002-09-17	日本光電工業株式会社	白血球分類用試薬および白血球分類方法
US5763280A (en) *	1997-01-21	1998-06-09	Coulter International Corp.	Cyanide-free lytic reagent composition and method for hemoglobin and cell analysis
JP3830613B2 (ja) *	1997-04-18	2006-10-04	シスメックス株式会社	血液中の白血球及びヘモグロビン濃度測定試薬
US6596706B1 (en) *	1997-11-07	2003-07-22	Daiichi Pharmaceutical Co., Ltd.	Piperazine-cyclodextrin complexes

1998
- 1998-05-07 FR FR9806055A patent/FR2778413B1/fr not_active Expired - Fee Related
1999
- 1999-05-04 ES ES99430007T patent/ES2141073T1/es active Pending
- 1999-05-04 AT AT99430007T patent/ATE237806T1/de not_active IP Right Cessation
- 1999-05-04 GR GR990300041T patent/GR990300041T1/el unknown
- 1999-05-04 EP EP99430007A patent/EP0955543B1/de not_active Expired - Lifetime
- 1999-05-04 DE DE0955543T patent/DE955543T1/de active Pending
- 1999-05-04 DE DE69906859T patent/DE69906859T2/de not_active Expired - Lifetime
- 1999-05-05 US US09/305,361 patent/US6143567A/en not_active Expired - Lifetime
- 1999-05-05 NZ NZ335594A patent/NZ335594A/en unknown
- 1999-05-06 NO NO992206A patent/NO992206L/no not_active Application Discontinuation
- 1999-05-06 AU AU26984/99A patent/AU747910B2/en not_active Ceased
- 1999-05-07 JP JP11127385A patent/JPH11352125A/ja not_active Withdrawn
2008
- 2008-06-23 JP JP2008163866A patent/JP4446059B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6143567A (en)	2000-11-07
EP0955543A1 (de)	1999-11-10
FR2778413B1 (fr)	2000-08-04
GR990300041T1 (en)	2000-01-31
AU2698499A (en)	2000-04-13
DE69906859D1 (de)	2003-05-22
JPH11352125A (ja)	1999-12-24
DE955543T1 (de)	2000-06-08
ES2141073T1 (es)	2000-03-16
JP4446059B2 (ja)	2010-04-07
JP2008224696A (ja)	2008-09-25
NO992206D0 (no)	1999-05-06
FR2778413A1 (fr)	1999-11-12
NZ335594A (en)	2000-02-28
ATE237806T1 (de)	2003-05-15
DE69906859T2 (de)	2004-01-29
AU747910B2 (en)	2002-05-30
EP0955543B1 (de)	2003-04-16

Legal Events

Date	Code	Title	Description
2007-01-15	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO992206D0 (no)	1999-05-06	Nye reagenser og en metode for lyse av erytrocytter
ATE450794T1 (de)	2009-12-15	Carbamatenthaltendes multifunktionelles erythrozytenreagenz und verwendungen
DE3584902D1 (de)	1992-01-30	Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
IL103056A (en)	1997-04-15	Method for sphering of red blood cells
ES2043762T3 (es)	1994-01-01	Reactivos desnaturalizantes para la determinacion conveniente de derivados de hemoglobina en sangre.
PL334793A1 (en)	2000-02-14	Reagent for measuring haemoglobin content and determining leukocytes in a blood sample
ES2185015T3 (es)	2003-04-16	Fluido para la recogida de muestras.
DE3751109D1 (de)	1995-04-06	Reagenzien zur Bestimmung von Peptidoglykan und beta-1,3-Glukan.
ATE191124T1 (de)	2000-04-15	Verwendung von d,l-alpha-liponsäure, ihren enantiomeren, und/oder ihren derivaten als zusatz bei erythrozyten-flüssig und -kryokonserven für homologe und autologe erythrozytenkonzentrate
ATE271220T1 (de)	2004-07-15	Borathaltige speicherpuffer und probenverdünner
AU625137B2 (en)	1992-07-02	Lithium salts as red blood cell lysing and hemoglobin denaturing reagents
ATE464562T1 (de)	2010-04-15	Lysereagens zur gleichzeitigen auszählung unterschiedlicher arten von blutzellen in einer blutprobe
ES516496A0 (es)	1983-06-01	"procedimiento para la determinacion de hemoglobina glucosilada".
ATE86669T1 (de)	1993-03-15	Zusammensetzung und verfahren zur stabilisierung von dinukleotiden.
Matsumoto et al.	1989	Determination of sulfite in white wine by amperometric flow injection analysis with an immobilized sulfite oxidase reactor
DK56386A (da)	1986-08-06	Reagens til ved haemagglunitation at bestemme antistoffer mod bakterielle toksiner, fremgangsmaade til fremstilling af reagenset og dettes anvendelse
PT83826B (pt)	1989-06-30	Processo para a preparacao dum reagente para a determinacao da actividade de peroxidase
GR3021133T3 (en)	1996-12-31	Analysis of hair
AU1659388A (en)	1988-12-01	A method and reagent for determining ld-1 isoenzyme
DK0625707T3 (da)	2000-03-27	Fremgangsmåde og præparat til lyse af erytrocytter, blodpræparat og fremgangsmåde til leukocytanalyse
DE3685922D1 (de)	1992-08-13	Verfahren und reagenz zur beseitigung der stoerung der analyt-wiederfindung in plasmaproben.
GB1245742A (en)	1971-09-08	Improvements in or relating to treatment of biological material
EP0248144A3 (en)	1989-03-08	Selective immunoassay for pro-urokinase and urokinase
DE60024923D1 (de)	2006-01-26	Verfahren zur Analyse der funktionellen Aktivierung von Leukocyten, Plättchen und anderen Zellen